BHC earnings call for the period ending December 31, 2018.
News & Analysis: Bausch Health Companies
The drugmaker posted a loss in the fourth quarter as sales declined for products facing generic rivals, but its organic revenue grew.
Find out why these stocks climbed on the first trading day of the year.
Bausch's comeback hit a minor stumbling block last month. Here's why.
BHC earnings call for the period ending September 30, 2018.
The drugmaker reported improving performance for all of its business segments in the third quarter.
Investors applauded news of the end of a patent fight.
Settlement of patent litigation provides a spark for Bausch Health.
BHC earnings call for the period ending June 30, 2018.
The drugmaker reported organic growth for the second consecutive quarter thanks in part to new product launches.